UV filters

Handbook of Cosmetic Science and Technology, Third Edition

Volumn , Issue , 2009, Pages 311-322

  Levy, Stanley B ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Revlon Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862332702     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (46)

1. Weinstock MA. Death from skin cancer among the elderly: epidemiological patterns. Arch Dermatol 1997; 133:1207-1209.
2. Yaar M, Gilchrest BA. Photoageing: mechanism, prevention and therapy. Br J Dermatol 2007; 157:874-887.
3. Kullavanijaya P, Lim HW. Photoprotection. J Am Acad Dermatol 2005; 52:937-958.
4. Gurish MF, Roberts LK, Krueger GG, et al. The effect of various sunscreen agents on skin damage and the induction of tumor susceptibility in mice subjected to ultraviolet irradiation. J Invest Dermatol 1975; 65:543-546.
5. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329:1147-1151.
6. Boyd AS, Naylor M, Cameron GS, et al. The effects of chronic sunscreen use on the histologic changes of dermatoheliosis. J Am Acad Dermatol 1995; 33:941-946.
7. van der Pols JC, Williams GM, Pandeya N, et al. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006; 15(12):2546-2548.
8. Roberts LK, Beasley DG. Commercial sunscreen lotions prevent ultraviolet-radiation-induced immune suppression of contact hypersensitivity. J Invest Dermatol 1995; 105:339-344.
9. Stiller MJ, Bartolone J, Stern R, et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin: a double-blind vehicle-controlled clinical trial. Arch Dermatol 1996; 132:631-636.
10. Huncharek M, Kupelnick B. Use of topical sunscreens and the risk of malignant melanoma: a metaanalyisi of 9067 patients from 11 case control studies. Am J Public Health 2002: 92:1173-1177.
11. CDC. Counseling to prevent skin cancer: recommendations and rationale of the US Preventative Services Task force. MMWR 2003; 52(No.RR-15):13-17.
12. Urbach F. The historical aspect of sunscreens. J Photochem Photobio 2001; 64:99-104.
13. Shaath NA. Sunscreen evolution. In: Shaath NA, ed. Sunscreens: Regulation and Commercial Development. 3rd. ed. Boca Raton: Taylor and Francis, 2005:218-238.
14. Rebut, R. The sunscreen industry in Europe: Past, present, and future. In: Lowe NJ, Shaath NA, eds. Sunscreens:Development, Evaluation, and Regulatory Aspects. New York: Marcel Dekker, 1990:161-178.
15. Moyal D, Chardon A, Kollias N. UVA protection efficacy of sunscreens can be determined by persistant pigment darkening (PPD) method. (Part 2). Photodermatol Photoimmunol Photomed 2000; 16:250-255.
16. Diffey BL, Tanner PR, Matts PJ, et al. In vitro assessment of the broad spectrum ultravioletprotection of sunscreen products. J Am Acad Dermatol 2000; 43:1024-1035.
17. Steinberg DC. Regulations of sunscreens worldwide. In: Shaath NA, ed. Sunscreens: Regulation and Commercial Development. 3rd. ed. Boca Raton: Taylor and Francis, 2005: 173-198.
18. Shaath NA. On the theory of ultraviolet absorption by sunscreen chemicals. J Soc Cosmet Chem 1987; 82:193.
19. Sayre RM, Killias N, Roberts RL, et al. Physical sunscreens. J Soc Cosmet Chem 1990; 41:103-109.
20. Wenninger JA, McEwen GN Jr., eds. International cosmetic ingredient dictionary and handbook. 12th ed. Washington: The Cosmetic, Toiletry, and Fragrance Association, 2008.
21. Steinberg DC. Frequency of use of organic UV filters as reported to the FDA. Cosmet Toilet 2003; 118:10:81-83.
22. Tuchinda C, Lim HW, Osterwalder MS, et al. Novel emerging sunscreen technologies. Dermatol Clin 2006; 24:145-117.
23. Herzog B, Hueglin D, Osterwalder U. New sunscreen actives. In: Shaath NA, ed. Sunscreens:Regulation and Commercial Development. 3rd ed. Boca Raton: Taylor and Francis, 2005: 218-238.
24. Deflandre A, Lang G. Photostability assessment of sunscreens. Benzylidene camphor and dibenzoylmethane derivatives. Int J Cosmet Sci 1988; 10:53-62.
25. Chatelain E, Gabard B. Photostabilization of butylmethoxybenzoylmethane (Avobenzone) and ethylhexyl methoxycinnamate by bis-ethylhexylphenol methoxy triazine (Tinisorb S), a new UV broadband filter. Photchem Photobiol 2001; 74:401-406.
26. Moyal D. Prevention of ultraviolet-induced skin pigmentation. Photodermatol Photoimmunol Photomed 2004; 20:243-247.
27. Seite S, Colige A, Piquemal-Vivenot P, et al. A full-spectrum absorbing daily use cream protects human skin against biological changes occuring in photoaging. Photodermatol Photoimmunol Photomed 2000; 16:147-155.
28. Murphy GM. Sunblocks: mechanisms of action. Photodermatol Photoimmunol Photomed 1999; 15:34-36.
29. Wamer WG, Yin JJ, Wei RR. Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radic Biol Med 1997; 23:851-858.
30. Diffey BL, Grice J. The influence of sunscreen type on photoprotection. Br J Dermatology 1999; 137:103-105.
31. Fairhurst D, Mitchnik MA. Particulate sun blocks: general principles. In: Lowe NJ, Shaath NA, Pathak MA, eds. Sunscreens: Development, Evaluation, and Regulatory Aspects. 2nd ed. New York:Marcel Dekker, 1997:313-352.
32. Mitchnick MA, Fairhurst D, Pinnell SR. Microfine zinc oxide (Z-Cote) as a photostable UVA/UVB sunblock agent. J Am Acad Dermatol 1999; 40:85-90.
33. Tanner PR. Sunscreen product formulation. Dermatol Clin 2006; 24:53-62.
34. Agin PP. Water resistance and extended wear sunscreens. Dermatol Clin 2006; 24:75-79.
35. Foley P, Nixon R, Marks R, et al. The frequency of reactions to sunscreens:results of a longitudinal population-based study on the regular use of sunscreens in Australia. Br J Dermatology 1993; 128:512-518.
36. Dromgoole SH, Maibach HI. Sunscreening agent intolerance:contact and photocontact sensitization and contact urticaria. J Am Acad Dermatol 1990; 22:1068-1078.
37. Fischer T, Bergstrom K, Evaluation of customers’ complaints about sunscreen cosmetics sold by the Swedish pharmaceutical company. Contact Dermatitis 1991; 25:319-322.
38. Schauder S, Ippen H. Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Dermatitis 1997; 37(5):221-232
39. Lenique P, Machet L, Vaillant L, et al. Contact and photocontact allergy to oxybenzone. Contact Dermatitis 1992; 26:177-181.
40. Nash JF. Human safety and efficacy of ultraviolet filters and sunscreen products. Dermatol Clin 2006; 24:35-51.
41. Fotiades J, Soter NA, Lim HW. Results of evaluation of 203 patients for photosensitivity in a 7.3-year period. J Am Acad Dermatol 1995; 33(4):597-602.
42. Trevisi P, Vincenzi C, Chieregato C, et al. Sunscreen sensitization. A three-year study. Dermatology 1994; 189:55-57.
43. Schlumpf M, Schmid P, Durrer S, et al. Endocrine activity and developmental toxicity of cosmetic UV filters-an update. Toxicology 2004; 205:113-122.
44. Janjua NR, Morgensen B, Anderson AM, et al. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol 2004; 123(1):57-61.
45. Agrapidis-Paloympis LE, Nash RA, Shaath NA. The effect of solvents on the ultraviolet absorbance of sunscreens. J Soc Cosmet Chem 1987; 38:209-221.
46. Klein K. Formulating sunscreen products. In: Lowe NJ, Shaath NA, eds. Sunscreens: Development, Evaluation, and Regulatory Aspects. New York: Marcel Dekker, 1990:235-266.